Sparrow Pharmaceuticals, Inc.

steroids - drugs like prednisone - are associated with 10% of all drug side effects and 10% of hospitalizations due to drugs. sparrow's patented new drugs (nces) can be the basis for new proprietary drugs with steroid efficacy and without many steroid side effects. our nces inhibit a key enzyme of steroid metabolism, so block a pathway that is responsible for many steroid side effects but is not essential for steroid efficacy. next-generation steroids will be combinations of an enzyme inhibitor with a steroid. those products can become the first medicines for millions of autoimmune disease, blood cancer, or transplanted organ patients that combine strong efficacy, safety, convenience, and cost-effectiveness. cushing's disease is a condition of extreme excess of the natural steroid cortisol. cushing's symptoms are the same as the side effects of steroid medications. cushing's patients with constitutively low activity of the enzyme inhibited by our nces show none of those symptoms. the